日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Targeting PFKFB3 to enhance CDK4/6 inhibitor response in ER+ breast cancer.

靶向 PFKFB3 以增强 ER+ 乳腺癌中 CDK4/6 抑制剂的反应。

Telang Sucheta, Clem Brian F, Miret Ariamna A Herrera, Price Leanne, Dougherty Susan M, Schmitz Anna, Yin Xinmin, Ma Xipeng, Zhang Xiang, Chesney Jason, Imbert-Fernandez Yoannis

Gender difference in the activity but not expression of estrogen receptors alpha and beta in human lung adenocarcinoma cells.

人类肺腺癌细胞中雌激素受体α和β的活性存在性别差异,但表达无性别差异

Dougherty Susan M, Mazhawidza Williard, Bohn Aimee R, Robinson Krista A, Mattingly Kathleen A, Blankenship Kristy A, Huff Mary O, McGregor William G, Klinge Carolyn M